<DOC>
	<DOCNO>NCT01451528</DOCNO>
	<brief_summary>This open label trial conduct investigate efficacy safety umbilical cord blood therapy chronic traumatic brain injury patient . The study hypothesis participant show significant improvement cognition function Umbilical cord blood ( UCB ) transplantation .</brief_summary>
	<brief_title>Allogeneic Umbilical Cord Blood Therapy Chronic TBI</brief_title>
	<detailed_description>Traumatic brain injury patient increase due various accident . After acute therapeutic intervention , rehabilitation conventional main treatment medication . However , chronic stage , seem limitation obtain functional improvement spite comprehensive rehabilitation . Cell therapy like Umbilical cord blood ( UCB ) transplantation show promising result many animal study . The mechanism neurological improvement fully understood . Stem cell include UCB expect secrete neurotrophic factor enhance brain function . In addition , anti-inflammatory effect UCB suggest . Autologous UCB available case fact . The aim clinical trial determine safety efficacy allogeneic UCB .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Chronic Traumatic Brain Injury Patient ( onset duration : 6 month ) Glasgow Outcome Scale : 2 , 3 , 4 , 5 High risk pneumonia renal function deterioration immunosuppressant Possibility drug hypersensitivity relate study remedy Intractable seizure disorder Poor cooperation guardian , include inactive attitude rehabilitation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Umbilical Cord Blood</keyword>
	<keyword>Allogeneic</keyword>
	<keyword>Traumatic Brain Injury</keyword>
</DOC>